Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?

J Gynecol Oncol. 2019 Nov;30(6):e116. doi: 10.3802/jgo.2019.30.e116.

Authors

Rongyu Zang¹, Jianqing Zhu²

Affiliations

¹ Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Fudan University Zhongshan Hospital, Shanghai, China. zang.rongyu@zs-hospital.sh.cn.
² Department of Gynecologic Oncology, University Cancer Hospital of Chinese Science Academy, Hangzhou, China.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Ovarian Epithelial*
Cytoreduction Surgical Procedures
Female
Humans
Neoplasm Recurrence, Local
Neoplasms, Glandular and Epithelial*
Ovarian Neoplasms*